Did You Know?

Editor’s Picks

Latest News

Intellipharmaceutics Announces FDA Advisory Committee Meeting for Aximris XR(TM) (Oxycodone Hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain

TORONTO, ON / ACCESSWIRE / December 5, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a...

MiOXSYS Male Infertility Test Will be Featured in Product Symposium at the 8th Annual Congress of the German Federation of Reproductive Biology and Medicine

ENGLEWOOD, CO / ACCESSWIRE / December 5, 2019 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing...

CORRECTING and REPLACING Nearly a Quarter of a Million Prescribers Using Surescripts Prescription Price Transparency Tool to View Patient Medication Cost Information

Washington, D.C., Leads the Nation with Nearly 50% of E-Prescribers Utilizing the Technology ARLINGTON, Va.--(BUSINESS WIRE)--#EHR--Eighth paragraph, fourth sentence of...

MediOrbis™ Broadens Global Reach, Telemedicine Access to Specialty Physicians: Expands Co-Branded Digital, Telehealth & Technology Platform with MediGuide Second Medical Opinion

CLEVELAND--(BUSINESS WIRE)--MediOrbis, a multi-specialty telemedicine and telehealth company with a first-of-its-kind chronic disease management (CDM) program, announces expanded access to...

error: Content is protected !!